Development of AE147 Peptide-Conjugated Nanocarriers for Targeting uPAR-Overexpressing Cancer Cells.

June Yong ParkYuseon ShinWoong Roeck WonChaemin LimJae Chang KimKioh KangPatihul HusniEun Seong LeeYu Seok Youn Kyung Taek Oh

Published in: International journal of nanomedicine (2021)

The AE147-nanocarrier showed potential for targeting metastatic tumor cells overexpressing uPAR and as a nanomedicine platform for theragnosis applications. These results suggest that this novel nano-platform will facilitate further advancements in cancer therapy.

Keyphrases

cancer therapy
drug delivery
high throughput
squamous cell carcinoma
small cell lung cancer
photodynamic therapy
risk assessment
human health
climate change